Andrew M, Liao L, Fujimoto M, Khoury J, Hwa V, Dauber A. PAPPA2 is a Novel Growth Promoting Therapeutic Agent: in Vivo and in Vitro Evidence. J Endocr Soc. 2018;2:646-656.
Cabrera-Salcedo C, Mizuno T, Tyzinski L, Andrew M, Vinks AA, Frystyk J, Wasserman H, Gordon CM, Hwa V, Backeljauw P, Dauber A. Pharmacokinetics of IGF-I in PAPP-A2 deficient patients, growth response, and effects on glucose and bone density. J Clin Endocrinol Metab. 2017;102:4568-4577.
Fujimoto M, Hwa V, Dauber A. Novel Modulators of the Growth Hormone-Insulin-like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2. J Clin Res Pediatr Endocrinol. 2017;9(Suppl 2):1-8.
Dauber A, Muñoz-Calvo MT, Barrios V, Domené HM, Kloverpris S, Serra-Juhé C, Desikan V, Pozo J, Muzumdar R, Martos-Moreno GÁ, Hawkins F, Jasper HG, Conover CA, Frystyk J, Yakar S, Hwa V, Chowen JA, Oxvig C, Rosenfeld RG, Pérez-Jurado LA, Argente J. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability. EMBO Mol Med. 2016;8(4):363-74.